Hence, integration of emerging biomarkers with enhanced sensitivity and specificity such as KIM-1 into clinical practice along with routine renal health checks may contribute to develop effective management strategies against pediatric renal diseases. The gene discussed is HAVCR1; the disease is kidney disorder.